研究单位：[1]H. Lundbeck A/S[2]Beijing Chaoyang Hospital Capital Medical University Beijing,China,100020[3]Xuanwu Hospital Capital Medical University Beijing,China,100053[4]Chinese PLA General Hospital Beijing,China,100853[5]Renmin Hospital of Wuhan University Beijing,China,430060[6]Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University) Beijing,China,610041[7]The First Hospital of Jilin University Changchun,China,130021[8]The Second Hospital of Jilin University Changchun,China,130022[9]The First Affiliated Hospital of Chongqing Medical University Chongqing,China,400016
研究目的：
This study evaluates the efficacy of eptinezumab to prevent migraine in patients with chronic migraine
